DE3235459

DE3235459

The invention relates to a new crystal modification of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine (cimetidine), a histamine H-2 receptor antagonist having the Formula (I) (I) as well as to a process for preparing same. In the description, this new m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PETHOE, HAJNALKA, BUDAPEST, HU, HARSANYI, KALMAN, BENKE, BELA, FARKAS, GEB. KIRJAK, MARIA, CSONGOR, EVA, DEUTSCH, GEB. JUHASZ, IDA, HEGEDUES, BELA, DOMANY, GYOERGY, RADO, ANDRAS, KREIDL, JANOS
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a new crystal modification of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine (cimetidine), a histamine H-2 receptor antagonist having the Formula (I) (I) as well as to a process for preparing same. In the description, this new modification is named N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine Z (cimetidine Z).